Can you provide the inactive ingredient list for ruxolitinib by apotex?

How do inactive ingredients in ruxolitinib tablets from Apotex differ from the brand version?

Ruxolitinib from Apotex uses microcrystalline cellulose, lactose monohydrate, hydroxypropyl cellulose, and magnesium stearate as inactive ingredients. The brand-name drug from Incyte uses similar fillers and binders but includes additional components such as colloidal silicon dioxide and sodium lauryl sulfate.

What safety considerations apply when switching from brand ruxolitinib to Apotex generic?

Switching to Apotex’s generic may expose patients to different allergens or excipients. Patients with known sensitivities to lactose or cellulose derivatives should verify compatibility with their pharmacist or doctor. The FDA requires generic manufacturers to demonstrate bioequivalence, but inactive ingredient lists can vary.

What is the complete inactive ingredient list for ruxolitinib by Apotex?

Apotex lists the following in its ruxolitinib tablets: microcrystalline cellulose, lactose monohydrate, hydroxypropyl cellulose, and magnesium stearate. This list is available on the company’s product insert or through databases such as DailyMed.

When does the patent for ruxolitinib expire?

Ruxolitinib patent protection expires in 2026. Biosimilars and generics from multiple companies, including Apotex, have already received FDA approval.